Corbus Pharmaceuticals Announces Resolution of Inflammation, Infection and Tissue Regeneration Conference

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory diseases, announced that it will be presenting at the Resolution of Inflammation, Infection and Tissue Regeneration Conference in partnership with the New York Academy of Sciences (NYAS), taking place on Tuesday, June 26, 2018 in New York City. Read more >>